Patents by Inventor Martha R. Stampfer

Martha R. Stampfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11293008
    Abstract: A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: April 5, 2022
    Assignee: The Regents of the University of California
    Inventors: Mark A. LaBarge, Martha R. Stampfer, James C. Garbe
  • Patent number: 10870851
    Abstract: Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: December 22, 2020
    Assignees: The Regents of the University of California, The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 10689652
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In finite lifespan pre-stasis human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed, and in post-stasis HMEC, the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation and immortalization during human carcinoma progression, methods for screening for toxic and environmental effect on progression, and the development of therapeutics targeting the process of immortalization.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: June 23, 2020
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20190352606
    Abstract: A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.
    Type: Application
    Filed: September 23, 2016
    Publication date: November 21, 2019
    Inventors: Mark A. LaBarge, Martha R. Stampfer, James C. Garbe
  • Publication number: 20180298382
    Abstract: Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Publication number: 20170130232
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In finite lifespan pre-stasis human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed, and in post-stasis HMEC, the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation and immortalization during human carcinoma progression, methods for screening for toxic and environmental effect on progression, and the development of therapeutics targeting the process of immortalization.
    Type: Application
    Filed: September 2, 2016
    Publication date: May 11, 2017
    Applicants: The Regents of the University of California, The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 9376662
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: June 28, 2016
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20150247121
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Application
    Filed: February 20, 2015
    Publication date: September 3, 2015
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20150225696
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed and the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed in post-stasis HMEC. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation, immortalization during human carcinoma progression, and methods for screening for toxic and environmental effect on progression.
    Type: Application
    Filed: October 2, 2014
    Publication date: August 13, 2015
    Applicants: The Regents of the University of California, THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 8962325
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: February 24, 2015
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20100022000
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Application
    Filed: September 30, 2008
    Publication date: January 28, 2010
    Applicant: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Patent number: 4808532
    Abstract: Substantially genetically stable continuous human cell lines derived from normal human mammary epithelial cells (HMEC) and processes for making and using the same. In a preferred embodiment, the cell lines are derived by treating normal human mammary epithelial tissue with a chemical carcinogen such as benzo[a]pyrene. The novel cell lines serve as useful substrates for elucidating the potential effects of a number of toxins, carcinogens and mutagens as well as of the addition of exogenous genetic material. The autogenic parent cells from which the cell lines are derived serve as convenient control samples for testing. The cell lines are not neoplastically transformed, although they have acquired several properties which distinguish them from their normal progenitors.
    Type: Grant
    Filed: July 1, 1985
    Date of Patent: February 28, 1989
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Martha R. Stampfer
  • Patent number: 4423145
    Abstract: Methods are disclosed for isolating and culturing human mammary epithelial cells of both normal and malignant origin. Tissue samples are digested with a mixture including the enzymes collagenase and hyaluronidase to produce clumps of cells substantially free from stroma and other undesired cellular material. Growing the clumps of cells in mass culture in an enriched medium containing particular growth factors allows for active cell proliferation and subculture. Clonal culture having plating efficiencies of up to 40% or greater may be obtained using individual cells derived from the mass culture by plating the cells on appropriate substrates in the enriched media. The clonal growth of cells so obtained is suitable for a quantitative assessment of the cytotoxicity of particular treatment. An exemplary assay for assessing the cytotoxicity of the drug adriamycin is presented.
    Type: Grant
    Filed: May 7, 1981
    Date of Patent: December 27, 1983
    Inventors: Martha R. Stampfer, Helene S. Smith, Adeline J. Hackett